跳至主要内容
临床试验/JPRN-UMIN000003983
JPRN-UMIN000003983已完成1 期

Convection-enhanced delivery of Nimustine Hydrochloride combined with oral temozolomide against recurrent malignant gliomas - CED of ACNU combined with oral TMZ against recurrent malignant gliomas

Department of Neurosurgery, Tohoku University Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2010年8月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Cases suffering active cancer 2) Cases suffering meningitis or pneumonia 3) Pregnant or breast feeding woman 4) Karnofsky performance status score less than 30 5) Cases suffering active inflammation 6) Cases with severe liver dysfunction 7) Cases with bone marrow insufficiency 8) Cases with renal failure 9) Cases with hemorrhagic diathesis 10) Cases taking anti-coagulative or anti-platelet agents 11) Cases with psychological diseases 12) Cases with uncontrolled Diabetes Mellitus 13) Cases suffered myocardial infarction within 3 months or cases with unstable angina 14) Cases that have history of pulmonary fibrosis or interstitial pneumoniae

研究者

发起方
Department of Neurosurgery, Tohoku University Graduate School of Medicine

相似试验